Cart (0 Items)
Your cart is currently empty.
View ProductsWhy choose us for your Therapeutic Antibody project?
We understand the challenges of antibody development and offer the support you need at every stage of your project.
ProteoGenix, a therapeutic antibody CRO solving challenges every day to de-risk your antibody development
You’re building therapeutic antibodies under constant pressure: timelines, risk, manufacturability, and decision-making with imperfect data.
Our therapeutic antibody services are designed for the realities of the market, helping you move faster to a lead candidate. Through our antibody discovery services and custom workflows, we combine advanced engineering, in silico insight, and wet-lab execution to de-risk selection, optimization, and developability.
Why therapeutic antibody programs slow down and how we keep them moving
Therapeutic antibody development brings hurdles that can slow progress and increase risk. We help you anticipate them early and move forward with the right strategy, data, and execution—while you retain full IP ownership, with zero royalties or milestone payments.
When membrane targets slow discovery, we restore signal with the right target presentation
Our antigen design services help preserve biologically relevant conformations, so screening starts from the right target. Backed by thousands of antibody development projects with complex membrane targets, we know the strengths and limits of each method and choose the most likely-to-work protocols for your target.
Discover your complex target services :
MHC-Peptide complex antibody service GPCR Antibody services Virus-Like Particle antibody services
Case report
Discover our TCR-like Antibody Development Service through a case report from one of our client’s projects.
Case Report: From pHLA Targeting to CAR-T Validation — 36 Positive Hits Identified & 3 High-Affinity Anti-pHLA Antibodies Delivered
Need fully human antibodies powered by human libraries and humanized mice
With ProteoGenix, access two proven routes to fully human antibody leads. You keep full freedom to operate with a clear, program-driven path from discovery to engineered candidates.
Phage display with high-diversity human libraries to deliver high-affinity sequences in 4 weeks
IP-free humanized mice to generate fully human antibodies shaped by in vivo affinity maturation
Securing the development of complex antibodies for the clinic
We help you turn challenging targets and complex formats into developable, clinic-ready candidates with end-use constraints in mind.
Our antibody engineering services support reformatting into bispecifics, CAR-T formats, and ADCs. For ADCs, our chemical and enzymatic conjugation delivers tight DAR control and >90% DAR homogeneity at your specified ratio.
Discover your services :
Bispecific antibody services
Anti-drug antibody services
Car-T-cell development services
Immunogenicity risk reduced with AI-guided antibody humanization
Our AI-guided humanization delivers optimized human sequences in 4 weeks to reduce immunogenicity risk. If you need stronger binding, our AI-powered affinity maturation service boosts affinity while preserving developability. Built on ~10B sequences and real project learnings, we provide quality control verified recombinant variants with functional validation. You can pick the right lead with confidence.
Case report
Discover our AI-Driven Antibody Humanization Service through a case report from one of our client’s projects
Case Report: From Mouse mAb to Human-Classified Leads — 22 Humanized Variants Designed, >80% Human Homology & Up to 2.6× Higher Apparent Binding (3 Lead Candidates Selected)
Preventing late-stage developability surprises to accelerate your path to the clinic
We optimize developability to secure a manufacturable lead faster. Within our antibody optimization services, we combine AI sequence analysis and WetLab assays to flag liabilities early and guide smarter variants. You can prioritize robust candidates with an actionable result report.
Discover our AI-driven antibody developability improvement service
Scale up your recombinant antibody production with a unique partner
Our recombinant antibody production services scale from µg to kg, your program can stay with one partner. Production, purification, and quality control are fully customizable, you pay only for what matters. Robust workflows and targeted characterization help you compare candidates and reduce risk.
Discover your service:
High throughput antibody production service
Transient expression services
Stable cell line development service
Case report
Discover our XtenCHO® Race Small-Scale High-Throughput Production workflow through a case report from one of our client’s projects
Case Report:Fast-Tracking Variant Selection with XtenCHO® Race — 18 Antibody Variants Produced in Parallel, ~2 to >7 mg per 30 mL & >90% Purity
It was a real pleasure working with the Proteogenix team. Everything went very smoothly, the coordination was close and efficient, and they were always quick to respond to any doubts or questions. We truly appreciated how attentive they were throughout the entire process; at all times, we felt the communication was fluid and proactive. The delivery timelines were perfectly met, which made the collaboration even more seamless. I’d be happy to work together with them again in the future.
